Liver Transplantation for Patients with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection with Special Reference to Hemophiliac Recipients in Japan

この論文にアクセスする

この論文をさがす

著者

    • EGUCHI SUSUMU
    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences
    • SOYAMA AKIHIKO
    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences
    • HIDAKA MASAAKI
    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences
    • MURAOKA IZUMI
    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences
    • TOMONAGA TETSUO
    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences
    • KANEMATSU TAKASHI
    • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences

抄録

Liver transplantation for patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) remains challenging. The advent of highly active antiretroviral therapy (HAART) for HIV has reduced mortality from opportunistic infection related to acquired immunodeficiency syndrome dramatically, while about 50% of patients die of end-stage liver cirrhosis resulting from HCV. In Japan, liver cirrhosis frequently develops after HCV-HIV coinfection resulting from previously transfused infected blood products for hemophilia. The problems of liver transplantation for those patients arise from the need to control calcineurin inhibitor with HAART drugs, the difficulty of using interferon after liver transplantation with HAART, and the need to control intraoperative coagulopathy associated with hemophilia. We review published reports of liver transplantation for these patients in the updated world literature.

収録刊行物

  • Surgery today : the Japanese journal of surgery

    Surgery today : the Japanese journal of surgery 41(10), 1325-1331, 2011-10-01

    Springer Verlag

参考文献:  58件中 1-58件 を表示

被引用文献:  3件中 1-3件 を表示

各種コード

ページトップへ